Tumor necrosis factor alpha converting enzyme: An encouraging target for various inflammatory disorders

Keyphrases

• Inflammatory Disorders 100%
• Tumor Necrosis Factor-α Converting Enzyme 100%
• Tumor Necrosis Factor-α 80%
• Disease Conditions 40%
• Matrix Metalloproteases 40%
• Autoimmune Disease 20%
• Clinical Trials 20%
• Inflammatory Conditions 20%
• Inhibitory Activity 20%
• Rheumatoid Arthritis 20%
• Active Form 20%
• Promising Treatment 20%
• Inflammatory Cytokines 20%
• Soluble Form 20%
• Novel Therapies 20%
• Enzyme Inhibition 20%
• Remicade 20%
• Anti-tumor Necrosis Factor Antibody 20%
• Enbrel 20%
• Humira 20%
• Angiotensin-converting Enzyme Inhibitor (ACEi) 20%
• Rheumatoid Arthritis Treatment 20%

Medicine and Dentistry

• Tumor Necrosis Factor 100%
• Inflammatory Disorder 100%
• Tumor Necrosis Factor Alpha Converting Enzyme 100%
• Rheumatoid Arthritis 50%
• Disease 25%
• Side Effect 25%
• Cytokine 25%
• Clinical Trial 25%
• Serositis 25%
• Inflammatory Cytokine 25%
• Enzyme Inhibition 25%
• Tumor Necrosis Factor Alpha Converting Enzyme Inhibitor 25%
• Adalimumab 25%
• Autoimmune Disease 25%
• Tumor Necrosis Factor Antibody 25%
• Etanercept 25%
• Infliximab 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Disease 100%
• Tumor Necrosis Factor Alpha Converting Enzyme 100%
• Tumor Necrosis Factor 80%
• Cytokine 40%
• Rheumatoid Arthritis 40%
• Clinical Trial 20%
• Enzyme Inhibition 20%
• Side Effect 20%
• Tumor Necrosis Factor Antibody 20%
• Tumor Necrosis Factor Alpha Converting Enzyme Inhibitor 20%
• Autoimmune Disease 20%
• Inflammation 20%
• Etanercept 20%
• Adalimumab 20%
• Infliximab 20%